CN110907545B - Method for simultaneously determining contents of six metabolites in small gold preparation - Google Patents

Method for simultaneously determining contents of six metabolites in small gold preparation Download PDF

Info

Publication number
CN110907545B
CN110907545B CN201911114537.XA CN201911114537A CN110907545B CN 110907545 B CN110907545 B CN 110907545B CN 201911114537 A CN201911114537 A CN 201911114537A CN 110907545 B CN110907545 B CN 110907545B
Authority
CN
China
Prior art keywords
acetonitrile
parts
metabolites
internal standard
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911114537.XA
Other languages
Chinese (zh)
Other versions
CN110907545A (en
Inventor
赵刚
熊登科
李霞
余丽花
吴雪英
郭平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jianmin Pharmaceutical Groups Corp ltd
Original Assignee
Jianmin Pharmaceutical Groups Corp ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jianmin Pharmaceutical Groups Corp ltd filed Critical Jianmin Pharmaceutical Groups Corp ltd
Priority to CN201911114537.XA priority Critical patent/CN110907545B/en
Publication of CN110907545A publication Critical patent/CN110907545A/en
Application granted granted Critical
Publication of CN110907545B publication Critical patent/CN110907545B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/36Control of physical parameters of the fluid carrier in high pressure liquid systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724Nebulising, aerosol formation or ionisation
    • G01N30/7266Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N2030/042Standards
    • G01N2030/045Standards internal

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a method for simultaneously measuring the contents of six metabolites in a Xiaojin preparation, wherein the six metabolites are aconitine, songorine, riolin, 3-acetyl-11-keto-beta-boswellic acid, 11-keto-beta-boswellic acid and wormcast element, and the measuring method comprises the following steps: 1) pretreating a plasma sample to obtain a sample solution to be detected; 2) and adding a positive ion internal standard and a negative ion internal standard into the sample solution to be detected, and carrying out HPLC-MS/MS detection. The invention establishes a convenient, accurate, sensitive and reliable LC-MS content determination method for six metabolites of the Xiaojin preparation in a living body for the first time, and the method can be applied to serum pharmacology research of the Xiaojin preparation and better monitor the pharmacokinetic process of a medicament in the body.

Description

Method for simultaneously determining contents of six metabolites in small gold preparation
Technical Field
The invention relates to a method for measuring the content of drug metabolites in a biological sample, in particular to a method for simultaneously measuring the content of six metabolites in a Xiaojin preparation.
Background
A traditional Chinese medicine with the effects of dissipating stagnation, relieving swelling, removing blood stasis and relieving pain is collected from the first part of the 2010 edition of Chinese pharmacopoeia, and the medicine is named as Xiaojin pill and is prepared from 10 traditional Chinese medicines of artificial musk, semen momordicae, radix aconiti agrestis, resina liquidambaris, frankincense, myrrh, trogopterus dung, angelica sinensis, earthworm, fragrant ink and the like. The formula is a classic and famous traditional Chinese medicine formula, and can be used for treating various difficult and complicated diseases such as goiter, benign prostatic hyperplasia, postherpetic neuralgia, cystic hyperplasia of breast, chronic pelvic inflammatory disease mass, nodular fasciitis and the like. At present, various preparations such as tablets, capsules and the like are on the market, for example, CN106265992A discloses Xiaojin capsules and a preparation method thereof, and CN102764311A discloses Xiaojin dispersible tablets and a preparation method thereof.
In order to find out the compatibility rule of the Chinese herbal compound and reveal the pharmacodynamic action mechanism and the material basis for treating diseases, the applicant carries out a great deal of basic research on the Xiaojin preparation on the basis of the prior research, wherein the basic research comprises the steps of extracting and separating the parts of the Chinese herbal medicine such as total polysaccharide, total saponin, total flavone and the like by adopting the modern extraction and separation technology and determining the effective part group by combining the pharmacodynamic test; meanwhile, serum pharmacology research is also carried out, and the pharmacologic actions of effective components entering the body, metabolites thereof and some endogenous products generated by the body after the action of the medicament are observed. In the research process, a series of compounds possibly having physiological activity, which enter blood serum after the small gold preparation is orally taken, are found for the first time, and in order to better monitor the pharmacokinetic process of the compounds in vivo, a convenient, accurate and sensitive content measurement method is needed to be established.
Disclosure of Invention
The invention aims to provide a method for simultaneously measuring the contents of six metabolites in a small gold preparation.
The Xiaojin preparation is prepared from the following raw materials in parts by weight: 1-20 parts of artificial musk, 40-60 parts of kusnezoff monkshood root, 20-40 parts of frankincense, 40-60 parts of trogopterus dung, 40-60 parts of earthworm, 40-60 parts of cochinchina momordica seed, 40-60 parts of sweetgum resin, 20-40 parts of myrrh, 20-40 parts of Chinese angelica and 1-10 parts of Chinese ink,
the six metabolites are aconitine, songorine, riolin, 3-acetyl-11-keto-beta-boswellic acid, and wormcast element, and their chemical structures are shown in figure 1.
The determination method comprises the following steps:
1) pretreating a plasma sample to obtain a sample solution to be detected;
2) adding a positive ion internal standard and a negative ion internal standard into a sample solution to be detected, and carrying out HPLC-MS/MS detection, wherein the stationary phase of the high-performance liquid phase is a C18 bonded silica gel chromatographic column, the mobile phase A is 0.05-0.5% formic acid aqueous solution, the mobile phase B is acetonitrile, gradient elution is adopted, the flow rate is 0.1-0.5mL/min, the column temperature is 25-40 ℃, the mass spectrum adopts a positive ion mode and a negative ion mode, an electrospray ionization ion source is adopted, the scanning mode is a multi-reaction ion monitoring mode, and under the positive ion mode, the detection of the aconitine, the aconine, the lionine, the 3-acetyl-11-keto-beta-boswellic acid, the 11-keto-beta-boswellic acid and the positive ion internal standard protopine is carried out; and detecting the earthworm element and the negative ion internal standard isofraxidin in a negative ion mode.
Preferably, the positive ion internal standard is protopine, and the negative ion internal standard is isofraxidin.
Preferably, the mobile phase a is 0.1% aqueous formic acid.
Preferably, the flow rate is 0.3 mL/min.
Preferably, the column temperature is 35 ℃.
Preferably, the gradient elution is in positive ion mode, 0.01-2.5min, 10-80% acetonitrile; 2.5-3.5min, 80-100% acetonitrile; 3.5-6min, 100% acetonitrile; 6-7min, 100-10% acetonitrile; 7-10min, 10% acetonitrile, 10min of single running time; under negative ion mode, 0.01-0.5min, 30% acetonitrile; 0.5-2min, 30-80% acetonitrile; 2-2.1min, 80-30% acetonitrile; 2.1-5min, 30% acetonitrile, 5min single run time.
Preferably, the drying gas temperature of the mass spectrum is 550 ℃; the air curtain air is 40 psi; the collision gas is medium; the ion spray voltage is 5500 (+)/4500 (-) V; the atomizing gas was 50psi and the auxiliary heating gas was 55 psi.
Preferably, the pretreatment method of the plasma sample is that the plasma sample is vortexed and shaken for 2min, centrifuged at 13000rpm at 4 ℃ for 10min, supernatant solution is removed, the solvent is volatilized by nitrogen, residues are redissolved by methanol solution, centrifuged at 13000rpm at 4 ℃ for 10min, and the supernatant solution is absorbed.
The invention establishes a convenient, accurate, sensitive and reliable LC-MS content determination method for six metabolites of a Xiaojin preparation in a living body for the first time, and the method can be applied to serum pharmacology research of the Xiaojin preparation and better monitors the pharmacokinetic process of a medicament in the body.
Drawings
FIG. 1 shows the structural formulae of six test compounds and 2 internal standard compounds.
FIG. 2 HPLC-MS/MS chromatograms of 6 test compounds and 2 internal standard compounds in female SD rat plasma. A: a blank plasma chromatogram of a rat; b: 6 chromatograms of the compounds to be detected and the internal standard mixed solution; c: adding 6 to-be-detected compounds and an internal standard mixed solution chromatogram map into blank plasma; d: the chromatogram of the plasma and the internal standard compound of the rat 45min after the oral administration of the small gold capsule. (1. aconitine, 2. songorine, 3. rioline, 4.AKBA, 5.KBA, 6. protopine (IS +), 7. imperial, 8. isofraxidin (IS-))
Detailed Description
The invention establishes and develops an HPLC-MS/MS quantitative analysis method of 6 biological metabolites in Chinese medicinal compound small gold capsules produced by Jianmin pharmaceutical industry group member company in rat plasma, and carries out methodology investigation of biological samples, including verification on aspects of specificity, linear range, lower limit of quantitation, precision, accuracy, matrix effect, stability and the like. Therefore, an accurate, rapid, stable and reliable analysis means is provided for the research of the pharmacokinetics of the multicomponent small gold capsules.
According to the principles of 'representative ingredients in monarch drugs and rare drugs, ingredients with large in vitro content, drug effect ingredients reported in literatures, representative ingredients of single drugs, representative ingredients of different compounds and the like', and the results of earlier researches on the medicinal chemistry of the minigold capsule serum of the applicant are combined, 6 ingredients of aconitine, lionoline, 3-acetyl-11-keto-beta-boswellic acid (AKBA), 11-keto-beta-boswellic acid (KBA) and earthworm are selected for carrying out methodology research. It mainly becomes three types: aconitine alkaloids such as aconine, pseudoaconitine and riolin; AKBA and KBA are triterpenic acid compounds; the earthworm element is a furan sulfonic acid compound newly found in earthworm, the metabolism rule in vivo of the earthworm element is not reported, and a theoretical basis can be provided for the subsequent research. The chemical structures of the 6 compounds are shown in figure 1.
1. Experimental materials
1.1 instruments
Figure GDA0002339260830000031
Figure GDA0002339260830000041
1.2 drugs and reagents
Drugs and reagents Production company State of the country
Aconitine China Institute for food and drug control China
Erpartum songaricum alkali SHANGHAI YUANYE BIOTECHNOLOGY Co.,Ltd. China
Liaolin SHANGHAI YUANYE BIOTECHNOLOGY Co.,Ltd. China
11-keto-beta-boswellic acid SHANGHAI YUANYE BIOTECHNOLOGY Co.,Ltd. China
3-acetyl-11-keto-beta-boswellic acid SHANGHAI YUANYE BIOTECHNOLOGY Co.,Ltd. China
Protopine (IS) China Institute for food and drug control China
Isofraxidin (IS) China Institute for food and drug control China
Xiaojin capsule (batch number: 20170231) Wuhan Jianmin group stocks Co Ltd China
Chloral hydrate SINOPHARM CHEMICAL REAGENT Co.,Ltd. China
Heparin sodium SINOPHARM CHEMICAL REAGENT Co.,Ltd. China
Methanol (quality spectrum level) Merck Germany
Acetonitrile (Mass spectrum level) Merck Germany
Formic acid (quality spectrum level) Sigma-Aldrich USA
Leucine enkephalin correction fluid Sigma-Aldrich USA
Ultrapure water (18.2 omega) MilliQ 50SP pure water system USA
Ethyl acetate Shanghai Rujie chemical Co., Ltd China
The earthworm extract is obtained by separating and purifying single medicine earthworm in the laboratory, and the structure of the earthworm extract is processed by nuclear magnetic resonance mass spectrum ( 1 H NMR, 13 C NMR), UPLC-Q-TOF-MS to verify that its structure is 2-hexyl-5-ethyl-furan-3-sulfonic acid. The purity of all standard compounds was higher than 98% by HPLC.
1.3 Experimental animals
Healthy, adult female SD rats weighing 200 + -20 g, provided by Shanghai Spart-Bikeka laboratory animals Co., Ltd., animal quality certification number: SCXK (Shanghai) 2018 and 0006. The animals are conventionally bred in experimental animal center of college of medicine of naval military medical university for 7 days, and are fed with standard feed and drinking water, and the room temperature is kept at 24 + -2 deg.C, relative humidity is kept at 55 + -5%, and dark illumination period is 12 h. Fasted for 12h before the experiment, but drinking water was still given.
2. Experimental methods and results
2.1 preparation of the solution
Respectively and precisely weighing 5.03mg, 4.95mg, 5.04mg, 4.98mg, 4.93mg and 4.90mg of aconitine, isosongorine, lyoxaline, AKBA, KBA and wormcast element standard substances, putting the weighed materials into a 5mL brown volumetric flask, firstly adding a proper amount of methanol solution for dissolving, then adding methanol to scale for constant volume, and uniformly mixing and shaking to obtain standard substance stock solutions with mass concentrations of 1.006mg/mL, 0.990mg/mL, 1.008mg/mL, 0.996mg/mL, 0.986mg/mL and 0.998 mg/mL.
Respectively and precisely weighing 5.0mg of internal standard protopine and isofraxidin standard, preparing a mixed internal standard stock solution with the mass concentration of 400ng/mL by using a methanol-acetonitrile (1:3, v/v) mixed solution, and storing the mixed internal standard stock solution in a refrigerator at the temperature of 4 ℃.
2.2 plasma sample Pre-treatment
Precisely measuring 180 mu L of blank plasma of a normal rat, placing the blank plasma into a 1.5mL EP tube, and respectively adding 20 mu L of mixed solution of 6 standard substances with various series concentrations and 800 mu L of mixed internal standard solution of protopine and isofraxidin with the solubility of 400 ng/mL. Vortex for 2min, centrifuge at 13000rpm for 10min at 4 ℃ and remove the supernatant solution in another clean 1.5mL EP tube. The solvent was evaporated at 35 ℃ with a nitrogen instrument, the residue was redissolved with 200. mu.L of methanol solution, centrifuged at 13000rpm for 10min at 4 ℃, the supernatant solution was aspirated, and 2. mu.L of sample was injected.
2.3 conditions of analysis
2.3.1 liquid phase conditions
An Agilent Eclipse Plus C18 (2.1X 100mm, 1.8 μm) column was used, and the mobile phase consisted of 0.1% (v/v) aqueous formic acid (A) and acetonitrile (B), with a flow rate of 0.3mL/min, a column temperature of 35 ℃ and a sample introduction of 2 μ L. The 6 compounds are collected in a positive and negative ion mode, and in order to shorten the collection time and improve the analysis efficiency, the elution gradient is respectively optimized in the positive and negative modes. In positive ion mode, 0.01-2.5min, 10-80% (v/v) acetonitrile; 2.5-3.5min, 80-100% acetonitrile; 3.5-6.0min, 100% acetonitrile; 6.0-7.0min, 100-10% acetonitrile; 7.0-10.0min, 10% acetonitrile, single run time of 10.0 min. Under the negative ion mode, 0.01-0.5min, 30% acetonitrile; 0.5-2.0min, 30-80% acetonitrile; 2.0-2.1min, 80-30% acetonitrile; 2.1-5.0min, 30% acetonitrile, 5.0min of single running time.
2.3.2 Mass Spectrometry conditions
AB SCIEX 4500QTRAP TM Mass Spectrometry (AB SCIEX, USA) by electrospray ionization (ESI) ion source and scanning modeIn multiple reaction ion monitoring mode (MRM). The atomizing gas, the drying gas and the collision gas are all nitrogen; temperature of the drying gas: 550 ℃, Curtain Gas (Curtain Gas): 40 psi; collision Gas (Collision Gas): medium; spray Voltage (Ionspray Voltage): 5500(+)/-4500(-) V; atomizing Gas (Gas 1): 50psi, auxiliary heating Gas (Gas 2): 55 psi. Using Analyst TM 1.6.3 the workstation performs the acquisition of mass spectral data. Detecting aconitine, songorine, riolin, AKBA, KBA and positive ion internal standard protopine in a positive ion mode; and detecting the earthworm element and the anion internal standard isofraxidin in the anion mode. The optimal MRM parameters for each component to be tested are shown in table 1.
TABLE 1 Primary and secondary ion pairs and MRM parameters of six compounds to be tested and two internal standard compounds
Figure GDA0002339260830000061
2.4 methodological considerations
2.4.1 specificity Studies
The method comprises the following steps of carrying out pretreatment on a biological sample according to a method under the item 2.2 on a rat blank plasma, a mixed solution of 6 compounds to be detected and an internal standard, a mixed solution of 6 compounds to be detected and the internal standard in the blank plasma, and a sample of the plasma of the rat and the internal standard after the mixed solution of the 6 compounds to be detected and the internal standard in the small gold capsule are orally administered for 45min, carrying out sample injection analysis and detection according to the conditions of liquid phase and mass spectrum under the item 2.3, and obtaining a chromatogram of the result shown in figure 2. The result shows that endogenous substances in rat plasma do not interfere with the detection of the 6 compounds to be detected and the internal standard, and the chromatographic behavior of the rat plasma added with the internal standard solution after the rat blank plasma is added with the 6 compounds to be detected and the internal standard solution is consistent with that of the rat plasma added with the internal standard solution after the small gold capsule is administrated.
2.4.2 Linear investigation
A pipetting gun precisely sucks 180 mu L of blank plasma, transfers the blank plasma to a blank 1.5mL EP tube, and respectively adds 20 mu L of mixed standard substance solutions of 6 compounds to be detected with different concentrations to prepare the following solutions with the mass concentrations: 0.10, 0.20, 1.00, 2.00, 5.00, 10.00, 20.00 and 40.00ng/mL of aconitine; 0.20, 0.40, 2.00, 4.00, 10.00, 20.00, 40.00 and 80.00ng/mL of isosongorine; riolline 0.50, 1.00, 5.00, 10.00, 25.00, 50.00, 100.00, 200.00 ng/mL; AKBA7.50, 15.00, 30.00, 75.00, 150.00, 375.00, 750.00, 1500.00 ng/mL; KBA7.50, 15.00, 30.00, 75.00, 150.00, 375.00, 750.00, 1500.00 ng/mL; the method comprises the steps of preprocessing a plasma sample of 25.00, 62.50, 125.00, 250.00, 625.00, 1250.00, 2500.00 and 5000.00ng/mL of the earthworm extract according to a method under the item '2.2', carrying out sample injection analysis and detection according to the conditions of liquid phase and mass spectrum under the item '2.3', recording data, drawing a standard curve, and calculating a linear regression equation of each compound, wherein the result is shown in a table 2. As a result, the compounds aconitine, songorine, riolin, AKBA, KBA and wormcast element have good linear relations in the ranges of 0.10-40.00ng/mL, 0.20-80.00ng/mL, 0.50-200.00ng/mL, 7.50-1500.00ng/mL, 7.50-1500.00ng/mL and 25.00-5000.00ng/mL respectively.
TABLE 2 regression equation and regression coefficient for six test compounds in rat plasma
Compound (I) Linear range/(ng/mL) Regression equation R
Aconitine 0.10~40.00 y=0.00322x+0.00119 0.9982
Erpartum songaricum alkali 0.20~80.00 y=0.0146x+0.00709 0.9910
Liaolin 0.50~200.00 y=0.0202x+0.0118 0.9946
AKBA 7.50~1500.00 y=0.1104x+0.0967 0.9927
KBA 7.50~1500.00 y=0.0284x-0.3621 0.9912
Earthworm element 25.00~5000.00 y=0.0065x+0.0477 0.9974
2.4.3 quantitative lower bound investigation
Precisely absorbing 180 mu L of blank plasma by a pipette, adding 20 mu L of 6 mixed solutions of compounds to be detected into a blank 1.5mL EP tube, preparing 5 parts of plasma sample solutions of 6 compounds to be detected with the mass concentrations of 0.10, 0.20, 0.50, 7.50 and 25.00ng/mL respectively, carrying out pretreatment on biological samples according to the method under the item '2.2', carrying out sample injection analysis and detection according to the conditions of liquid phase and mass spectrum under the item '2.3', recording data, analyzing the actual solubility of the sample, and calculating the RSD value. The results are shown in Table 3. As can be seen from the data in the table, the RSD value is within the range of 5.11-11.02%, which is less than 15%, and meets the analysis requirement of the plasma sample.
Table 3 lower limit of aconitine quantitation in rat plasma (n ═ 5)
Figure GDA0002339260830000071
2.4.4 precision investigation
Precisely absorbing 180 mu L of blank plasma by a pipette gun into a blank 1.5mL EP tube, adding 20 mu L of mixed solution of 6 compounds to be detected, and preparing four Quality Control (QC) samples with quantitative lower limit, low concentration, medium concentration and high concentration of the 6 compounds to be detected, wherein each concentration is prepared in parallel by 5 parts, namely the concentration of the aconitine is 0.10, 0.30, 5.00 and 32.00 ng/mL; the concentrations of the songorine are 0.20, 0.60, 10.00 and 64.00 ng/mL; the concentration of Rioprolin is 0.50, 1.50, 25.00, 160.00 ng/mL; the concentration of AKBA is 7.50, 22.50, 150.00 and 1200.00 ng/mL; KBA concentration is 7.50, 22.50, 150.00, 1200.00 ng/mL; plasma samples with the concentrations of the earthworm element of 25.00, 75.00, 625.00 and 4000.00 ng/mL. The pretreatment of the biological sample is carried out according to the method under the item 2.2, the injection analysis and detection are carried out according to the conditions of liquid phase and mass spectrum under the item 2.3, the actual solubility is analyzed by recording data, and the day-to-day precision are calculated. The results are shown in tables 4-1 to 4-6, and show that the RSD is between 2.11 and 10.48 percent and less than 15 percent, which meets the analysis requirement of the plasma sample.
Table 4-1 precision measurement of aconitine in rat plasma (n ═ 5)
Figure GDA0002339260830000081
Table 4-2 precision determination of songorine in rat plasma (n ═ 5)
Figure GDA0002339260830000082
Table 4-3 determination of lioline precision in rat plasma (n ═ 5)
Figure GDA0002339260830000083
Figure GDA0002339260830000091
Table 4-4 AKBA precision determination in rat plasma (n ═ 5)
Figure GDA0002339260830000092
Table 4-5 results of KBA precision measurement in rat plasma (n ═ 5)
Figure GDA0002339260830000093
Table 4-6 precision measurement of wormcast in rat plasma (n ═ 5)
Figure GDA0002339260830000094
2.4.5 accuracy survey
In the experiment, SD rat blank plasma is used for accuracy (namely relative recovery rate) inspection, a liquid transfer gun precisely sucks 180 mu L of blank plasma into a blank 1.5mL EP tube, 20 mu L of mixed solution of 6 compounds to be detected is added to prepare Quality Control (QC) samples with four levels of concentration, namely lower limit of quantitation, low concentration, medium concentration and high concentration, of the 6 compounds to be detected, and 5 parts of aconitine is prepared in parallel for each concentration, namely the concentration of aconitine is 0.10, 0.30, 5.00 and 32.00 ng/mL; the concentrations of the songorine are 0.20, 0.60, 10.00 and 64.00 ng/mL; the concentration of Rioprolin is 0.50, 1.50, 25.00, 160.00 ng/mL; the concentration of AKBA is 7.50, 22.50, 150.00 and 1200.00 ng/mL; KBA concentrations are 7.50, 22.50, 150.00, 1200.00 ng/mL; plasma samples with the concentrations of the earthworm element of 25.00, 75.00, 625.00 and 4000.00 ng/mL. The method comprises the following steps of pretreating a biological sample according to the method under the item 2.2, carrying out sample injection analysis and detection according to the conditions of a liquid phase and a mass spectrum under the item 2.3, recording data to analyze the actual solubility of the biological sample, and calculating the accuracy (namely the relative recovery rate) by using the ratio of the actually measured concentration to the labeled concentration, wherein the relative recovery rate of 6 compounds is 85.580-108.250%, and the RSD is 0.75-11.72% and is less than 15% in the tables 5-1 to 5-2. Namely, the accuracy of the 6 compounds in the method is good, and the method meets the analysis requirement of biological samples.
TABLE 5-1 accuracy of aconitine in rat plasma (n ═ 5)
Figure GDA0002339260830000101
Figure GDA0002339260830000111
TABLE 5-2 accuracy determination of aconitine in rat plasma (n ═ 5)
Figure GDA0002339260830000112
Table 5-3 determination of lioalin accuracy in rat plasma (n ═ 5)
Figure GDA0002339260830000121
Table 5-4 AKBA accuracy in rat plasma (n ═ 5)
Figure GDA0002339260830000122
Figure GDA0002339260830000131
Table 5-5 results of KBA accuracy determination in rat plasma (n ═ 5)
Figure GDA0002339260830000132
Figure GDA0002339260830000141
Table 5-6 accuracy measurement of wormcast in rat plasma (n ═ 5)
Figure GDA0002339260830000142
2.4.6 matrix Effect investigation
Precisely absorbing 180 mu L of blank plasma by a liquid-transfering gun into a blank 1.5mL EP tube, adding 20 mu L of a mixed solution of 6 compounds to be detected to prepare a quality control sample containing the 6 compounds to be detected in three concentration levels of low concentration, medium concentration and high concentration, preparing 6 parts of each concentration in parallel, carrying out pretreatment on a biological sample according to a method under the item '2.2', carrying out sample injection analysis and detection according to the conditions of liquid phase and mass spectrum under the item '2.3', and recording the peak areas of aconitine, isoleucamitine, orilin, AKBA, KBA and wormcrin as A1; in addition, 180 μ L of purified water is used to replace 180 μ L of blank plasma, and the other operations are the same as the above, and the peak area of the aconitine, the isosbaconine, the riolin, the AKBA, the KBA and the chrysopharin is recorded as A2, so that the matrix effect of the aconitine, the isosbaconine, the riolin, the AKBA, the KBA and the chrysopharin is as follows: (A1/A2). times.100%. No matrix effect was observed if all the biological samples obtained A1/A2 ranged from 85% to 115%. The experimental results are shown in table 6, the matrix effect of 6 compounds is between 93.45% and 100.64%, and the RSD is between 1.27% and 5.13%, which meets the requirements of biological sample quantification.
Table 6 rat plasma 6 test compounds and internal standard matrix effect (n ═ 6)
Figure GDA0002339260830000151
Figure GDA0002339260830000161
2.4.7 stability examination
Precisely absorbing 180 mu L of blank plasma by a pipette into a blank 1.5mL EP tube, adding 20 mu L of mixed solution of 6 compounds to be detected, preparing Quality Control (QC) samples with three grades of low concentration, medium concentration and high concentration of the 6 compounds to be detected, and preparing 5 parts of each concentration in parallel, namely the concentration of the aconitine is 0.30, 5.00 and 32.00 ng/mL; the concentrations of the songorine are 0.60, 10.00 and 64.00 ng/mL; the concentration of the Rio' ulin is 1.50, 25.00, 160.00 ng/mL; the concentration of AKBA is 22.50, 150.00, 1200.00 ng/mL; KBA concentrations are 22.50, 150.00, 1200.00 ng/mL; plasma samples with the concentrations of the earthworm element of 75.00, 625.00 and 4000.00ng/mL were examined for short-term stability and long-term stability of 6 test compounds in the plasma. Wherein the short-term stability investigation mainly comprises investigating room temperature placement stability, automatic sampler stability and repeated freeze-thaw stability; the long-term stability was evaluated by examining the stability of the plasma samples after 20 days of storage in a refrigerator at-80 ℃ and the results are shown in tables 7-1 to 7-4. According to the results, the RSD is between 1.27% and 8.49% and less than 15%, namely, the quality control samples with 3 concentrations of low concentration, medium concentration and high concentration of aconitine, isosbonoconine, riolin, AKBA, KBA and wormcast element show good stability in short-term and long-term investigation, and meet the analysis conditions of biological samples.
Table 7-1 stability of 6 test compounds in rat plasma at room temperature (n ═ 5)
Figure GDA0002339260830000162
Figure GDA0002339260830000171
Table 7-2 rat plasma 6 compounds tested autosampler stability (n ═ 5)
Figure GDA0002339260830000172
Table 7-3 repeated freeze-thaw stability of 6 compounds tested in rat plasma (n ═ 5)
Figure GDA0002339260830000173
Figure GDA0002339260830000181
Table 7-4 long term stability of 6 compounds tested in rat plasma (n ═ 5)
Figure GDA0002339260830000182
Figure GDA0002339260830000191
3. Small knot
The invention establishes a sensitive, rapid, simple, convenient and stable in vivo content determination method for simultaneously determining 6 small gold capsule metabolites, namely, aconine, isosongorine, riolin, AKBA, KBA and wormcast element, and internal standard protopine and isofraxidin in a biological sample based on HPLC-MS/MS. Collecting aconitine, songorine, lionoline, AKBA, KBA and internal standard protopine in positive ion mode for 10 min; the earthworm element and the internal standard isofraxidin are collected in a negative ion mode, and the analysis time is 5 minutes. And the methodology investigation of biological samples is carried out, the established LC-MS/MS determination method is examined from the aspects of specificity, linear range, lower limit of quantification, precision, accuracy, matrix effect, stability and the like, all the investigation results accord with the analysis requirements of the biological samples, and the established 6 metabolic products are simple, stable and reliable in analysis method and can be used for determining the blood concentration of the 6 metabolic products in the rat body.

Claims (4)

1. A method for simultaneously determining the contents of six metabolites in a Xiaojin preparation is disclosed, wherein the Xiaojin preparation is prepared from the following raw materials in parts by weight: 1-20 parts of artificial musk, 40-60 parts of kusnezoff monkshood root, 20-40 parts of frankincense, 40-60 parts of trogopterus dung, 40-60 parts of earthworm, 40-60 parts of momordica cochinchinensis, 40-60 parts of sweetgum resin, 20-40 parts of myrrh, 20-40 parts of Chinese angelica and 1-10 parts of Chinese ink, and is characterized in that: the six metabolites are aconitine, songorine, riolin, 3-acetyl-11-keto-beta-boswellic acid, 11-keto-beta-boswellic acid and wormcast element, and the determination method comprises the following steps:
1) pretreating a plasma sample to obtain a sample solution to be detected, wherein the pretreatment method of the plasma sample comprises the following steps: precisely measuring 180 mu L of blank plasma of a normal rat, placing the blank plasma in a 1.5mL EP tube, and respectively adding 20 mu L of mixed solution of 6 standard substances with various series concentrations and 800 mu L of mixed internal standard solution of protopine and isofraxidin with the solubility of 400 ng/mL; vortex and shake for 2min, centrifuge at 13000rpm for 10min at 4 ℃, and remove supernatant solution and put in another clean 1.5mL EP tube; volatilizing solvent at 35 deg.C with nitrogen instrument, re-dissolving residue with 200 μ L methanol solution, centrifuging at 13000rpm at 4 deg.C for 10min, sucking supernatant solution, and injecting 2 μ L sample;
after the small gold capsule is orally administrated for 45min, a sample of the plasma of a rat and an internal standard compound is treated according to the pretreatment method;
the solvent of the mixed internal standard solution is a methanol-acetonitrile mixed solution with the volume ratio of 1: 3;
2) performing HPLC-MS/MS detection, wherein the chromatographic column is an Agilent Eclipse Plus C18 chromatographic column with the specification of 2.1 × 100mm and 1.8 μm, the mobile phase A is 0.05-0.5% formic acid aqueous solution, the mobile phase B is acetonitrile, gradient elution is adopted, the flow rate is 0.1-0.5mL/min, the column temperature is 25-40 ℃, the mass spectrum adopts a positive ion mode and a negative ion mode, an electrospray ionization ion source is adopted, the scanning mode is a multi-reaction ion monitoring mode, and aconitine, pseudo-songorine, riolin, 3-acetyl-11-keto-beta-boswellic acid, 11-keto-beta-boswellic acid and positive ion internal standard protopine are detected in a positive ion mode; detecting the earthworm element and anion internal standard isofraxidin in the anion mode,
the gradient elution is carried out in a positive ion mode for 0.01-2.5min and 10-80% of acetonitrile; 2.5-3.5min, 80-100% acetonitrile; 3.5-6min, 100% acetonitrile; 6-7min, 100-10% acetonitrile; 7-10min, 10% acetonitrile, and 10min of single operation time; under the negative ion mode, 0.01-0.5min, 30% acetonitrile; 0.5-2min, 30-80% acetonitrile; 2-2.1min, 80-30% acetonitrile; 2.1-5min, 30% acetonitrile, 5min of single running time;
the drying gas temperature of the mass spectrum is 550 ℃; the air curtain air is 40 psi; the collision gas is medium; the ion spraying voltage is + 5500/-4500V; the atomizing gas was 50psi and the auxiliary heating gas was 55 psi.
2. The method for simultaneously determining the contents of six metabolites in a Xiaojin preparation as claimed in claim 1, wherein: the mobile phase a was 0.1% aqueous formic acid.
3. The method for simultaneously determining the contents of six metabolites in a Xiaojin preparation as claimed in claim 1, wherein: the flow rate was 0.3 mL/min.
4. The method for simultaneously determining the contents of six metabolites in a Xiaojin preparation as claimed in claim 1, wherein: the column temperature was 35 ℃.
CN201911114537.XA 2019-11-14 2019-11-14 Method for simultaneously determining contents of six metabolites in small gold preparation Active CN110907545B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911114537.XA CN110907545B (en) 2019-11-14 2019-11-14 Method for simultaneously determining contents of six metabolites in small gold preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911114537.XA CN110907545B (en) 2019-11-14 2019-11-14 Method for simultaneously determining contents of six metabolites in small gold preparation

Publications (2)

Publication Number Publication Date
CN110907545A CN110907545A (en) 2020-03-24
CN110907545B true CN110907545B (en) 2022-08-23

Family

ID=69817735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911114537.XA Active CN110907545B (en) 2019-11-14 2019-11-14 Method for simultaneously determining contents of six metabolites in small gold preparation

Country Status (1)

Country Link
CN (1) CN110907545B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2185825A1 (en) * 1994-03-18 1995-09-28 Fujio Suzuki Agent for the treatment of infections
CN102114090A (en) * 2009-12-30 2011-07-06 成都永康制药有限公司 Preparation and medical use of minor gold pills for male testicular nodular lesions
CN105486775B (en) * 2016-01-08 2017-08-04 首都医科大学 The detection method of Multiple components content in a kind of Yougui Wan, the kidney-Yang-Reinforcing Bolus
CN107727754B (en) * 2017-09-01 2020-07-10 健民药业集团股份有限公司 HP L C fingerprint detection method of Xiaojin preparation
CN108445115B (en) * 2018-06-15 2021-01-01 四川省中医药科学院 Method for simultaneously detecting Niaoling, Songguoling and fuziline by high performance liquid chromatography

Also Published As

Publication number Publication date
CN110907545A (en) 2020-03-24

Similar Documents

Publication Publication Date Title
CN109239224B (en) Method for simultaneously and quantitatively measuring 9 blood-entering components in spina date seed water extract
CN109324126B (en) Method for simultaneously determining 9 chemical components in spina date seeds by using UPLC-MS/MS
CN107607649B (en) Method for detecting periploca forrestii schltr
CN107449846B (en) Method for measuring effective components in infantile nerve-soothing and brain-nourishing granules by HPLC-MS (high Performance liquid chromatography-Mass Spectrometry)
CN115144507B (en) Method for simultaneously measuring active ingredients in Sang Ren lung-heat clearing oral liquid
CN103575830A (en) Analysis method for four anthraquinones in blood plasma and application of four anthraquinones in pharmacokinetics
CN107764908A (en) A kind of method for determining alkaloid component content in blood-nourishing and brain-refreshing the water extracted immersing paste
CN102288712B (en) Method for simultaneous determination of piperine content and piperlonguminine content in long piper extract through HPLC (high performance liquid chromatography)
CN110907545B (en) Method for simultaneously determining contents of six metabolites in small gold preparation
CN104634911B (en) A kind of 4 kinds of flavonoids effective constituent detection methods of CHUANKEZHI ZHUSHEYE
CN103487539B (en) Method for determining contents of albendazole and metabolites thereof in hemolymph of Bombyx mori by using ultra-fast liquid chromatography/triple-quadrupole tandem mass spectrometry (UFLC-MS/MS)
CN110988198A (en) Content determination method of bi-tong ning capsules
CN110687219B (en) Detection method of suhuang cough-relieving capsule fingerprint and application thereof
CN107589213A (en) A kind of toad skin medicinal material or medicine materical crude slice or the method for quality control for including toad leather agent
CN111024875B (en) Construction method of abrus cantoniensis hance amide component liquid chromatography fingerprint
CN113533584A (en) Simultaneous quantitative detection method and application of 2 blood-entering components in trichosanthes, allium macrostemon and pinellia ternate preparation
CN106841451A (en) The assay method of cumarin and its metabolin in mouse blood based on Ultra Performance Liquid Chromatography track trap high resolution mass spectrum
CN103575820A (en) Analysis method for five flavonoid glycosides in blood plasma and application of five flavonoid glycosides in pharmacokinetics
CN113933436A (en) Method for measuring contents of various components in caulis et folium piperis nigri medicinal material
CN109298081B (en) Method for determining impurity A biological sample in Cetilistat
CN101596274A (en) The method of quality control of Fructus Schisandrae Chinensis in the YIXINSHU Chinese medicine preparation
CN112213410A (en) Method for detecting ginkgo leaves
CN112198269A (en) Method for determining hydroxytyrosol in Beagle dog plasma
CN105259262A (en) Novel method for fast finding low-content active ingredients in natural products
CN106053641B (en) After oral lamiophlomis rotata in rat plasma flax category glycosides content measuring method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant